Nuclear factor-κB modulates osteogenesis of periodontal ligament stem cells through competition with β-catenin signaling in inflammatory microenvironments

Cell Death and Disease

Volumn 4, Issue 2, 2013, Pages

  Chen, X ^a   Hu, C ^a,b   Wang, G ^a   Li, L ^a   Kong, X ^a   Ding, Y ^a   Jin, Y ^a,b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Engineering Technology Center for Tissue Engineering of Xi'an   (China)

Author keywords

GSK 3 ; Inflammation; NF B; Osteogenic differentiation; Periodontal ligament stem cell

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LICL; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ARTICLE; BONE DEVELOPMENT; BONE DISEASE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MICROENVIRONMENT; PERIODONTAL LIGAMENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STEM CELL;

ADULT; ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; CELLS, CULTURED; CELLULAR MICROENVIRONMENT; CHROMONES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INFLAMMATION; LITHIUM CHLORIDE; MESENCHYMAL STROMAL CELLS; MICE; MORPHOLINES; NF-KAPPA B; NITRILES; OSTEOGENESIS; PERIODONTAL LIGAMENT; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SULFONES; TRANSCRIPTION FACTOR RELA; WNT SIGNALING PATHWAY;

MUS;

EID: 84875969826     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.14     Document Type: Article

References (44)

1. Wehling N, Palmer GD, Pilapil C, Liu F, Wells JW, Muller PE et al. Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaB-dependent pathways. Arthritis Rheum 2009; 60: 801-812.
2. Huang H, Kim HJ, Chang EJ, Lee ZH, Hwang SJ, Kim HM et al. IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ 2009; 16: 1332-1343.
3. Papadopoulou A, Yiangou M, Athanasiou E, Zogas N, Kaloyannidis P, Batsis I et al. Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis. Ann Rheum Dis 2012; 71: 1733-1740.
4. Park JC, Kim JM, Jung IH, Kim JC, Choi SH, Cho KS et al. Isolation and characterization of human periodontal ligament (PDL) stem cells (PDLSCs) from the inflamed PDL tissue: in vitro and in vivo evaluations. J Clin Periodontol 2011; 38: 721-731.
5. Nagatomo K, Komaki M, Sekiya I, Sakaguchi Y, Noguchi K, Oda S et al. Stem cell properties of human periodontal ligament cells. J Periodontal Res 2006; 41: 303-310.
6. Chen SC, Marino V, Gronthos S, Bartold PM. Location of putative stem cells in human periodontal ligament. J Periodontal Res 2006; 41: 547-553.
7. Seo BM, Miura M, Gronthos S, Bartold PM, Batouli S, Brahim J et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004; 364: 149-155.
8. Liu Y, Liu W, Hu C, Xue Z, Wang G, Ding B et al. MiR-17 modulates osteogenic differentiation through a coherent feed-forward loop in mesenchymal stem cells isolated from periodontal ligaments of patients with periodontitis. Stem Cells 2011; 29: 1804-1816.
9. Liu N, Shi S, Deng M, Tang L, Zhang G, Ding B et al. High levels of beta-catenin signaling reduce osteogenic differentiation of stem cells in inflammatory microenvironments through inhibition of the noncanonical Wnt pathway. J Bone Miner Res 2011; 26: 2082-2095.
10. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 2001; 107: 7-11.
11. Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA. Possible new role for NF-kappaB in the resolution of inflammation. Nat Med 2001; 7: 1291-1297.
12. Yamazaki M, Fukushima H, Shin M, Katagiri T, Doi T, Takahashi T et al. Tumor necrosis factor alpha represses bone morphogenetic protein (BMP) signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB. J Biol Chem 2009; 284: 35987-35995.
13. Gotschel F, Kern C, Lang S, Sparna T, Markmann C, Schwager J et al. Inhibition of GSK3 differentially modulates NF-kappaB, CREB, AP-1 and beta-catenin signaling in hepatocytes, but fails to promote TNF-alpha-induced apoptosis. Exp Cell Res 2008; 314: 1351-1366.
14. Chang J, Wang Z, Tang E, Fan Z, McCauley L, Franceschi R et al. Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med 2009; 15: 682-689.
15. Barre B, Perkins ND. Phosphorylation of the p52 NF-kappaB subunit. Cell cycle 2010; 9: 4774-4775.
16. Stambolic V, Ruel L, Woodgett Jr. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 1996; 6: 1664-1668.
17. Haefner B. A model for NF-kappa B regulation by GSK-3 beta. Drug Discov Today 2003; 8: 1062-1063.
18. Schwabe RF, Sakurai H. IKKbeta phosphorylates p65 at S468 in transactivaton domain 2. FASEB J 2005; 19: 1758-1760.
19. Barre B, Perkins ND. The Skp2 promoter integrates signaling through the NF-kappaB, p53, and Akt/GSK3beta pathways to regulate autophagy and apoptosis. Mol Cell 2010; 38: 524-538.
20. Itoh S, Saito T, Hirata M, Ushita M, Ikeda T, Woodgett JR et al. GSK-3alpha and GSK- 3beta proteins are involved in early stages of chondrocyte differentiation with functional redundancy through RelA protein phosphorylation. J Biol Chem 2012; 287: 29227-29236.
21. Karrasch T, Spaeth T, Allard B, Jobin C. PI3K-dependent GSK3ss(Ser9)-phosphorylation is implicated in the intestinal epithelial cell wound-healing response. PloS one 2011; 6: e26340.
22. Novack DV. Role of NF-kappaB in the skeleton. Cell Res 2011; 21: 169-182.
23. Li Y, Li A, Strait K, Zhang H, Nanes MS, Weitzmann MN. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB. J Bone Miner Res 2007; 22: 646-655.
24. Gambardella A, Nagaraju CK, O'Shea PJ, Mohanty ST, Kottam L, Pilling J et al. Glycogen synthase kinase-3alpha/beta inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage. J Bone Miner Res 2011; 26: 811-821.
25. Suzawa M, Takada I, Yanagisawa J, Ohtake F, Ogawa S, Yamauchi T et al. Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade. Nat Cell Biol 2003; 5: 224-230.
26. Markel TA, Crisostomo PR, Wang M, Wang Y, Lahm T, Novotny NM et al. TNFR1 signaling resistance associated with female stem cell cytokine production is independent of TNFR2- mediated pathways. Am J Physiol Regul Integr Comp Physiol 2008; 295: R1124-R1130.
27. Okamoto H, Kimura M, Watanabe N, Ogihara M. Tumor necrosis factor (TNF) receptor-2- mediated DNA synthesis and proliferation in primary cultures of adult rat hepatocytes: The involvement of endogenous transforming growth factor-alpha. Eur J Pharmacol 2009; 604: 12-19.
28. Wong BR, Josien R, Lee SY, Vologodskaia M, Steinman RM, Choi Y. The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor. J Biol Chem 1998; 273: 28355-28359.
29. Armaka M, Apostolaki M, Jacques P, Kontoyiannis DL, Elewaut D, Kollias G. Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases. J Exp Med 2008; 205: 331-337.
30. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Axin Kikuchi A. a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 1998; 17: 1371-1384.
31. Doble BW, Patel S, Wood GA, Kockeritz LK, Woodgett Jr. Functional redundancy of GSK- 3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev Cell 2007; 12: 957-971.
32. Ougolkov AV, Bone ND, Fernandez-Zapico ME, Kay NE, Billadeau DD. Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells. Blood 2007; 110: 735-742.
33. Buss H, Dorrie A, Schmitz ML, Frank R, Livingstone M, Resch K et al. Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity. J Biol Chem 2004; 279: 49571-49574.
34. Itoh S, Saito T, Hirata M, Ushita M, Ikeda T, Woodgett JR et al. GSK-3alpha and GSK-3beta are involved in early stages of chondrocyte differentiation with functional redundancy through RelA phosphorylation. J Biol Chem 2012; 287: 29227-29236.
35. Graham JR, Tullai JW, Cooper GM. GSK-3 represses growth factor-inducible genes by inhibiting NF-kappaB in quiescent cells. J Biol Chem 2010; 285: 4472-4480.
36. Zhao L, Lee JY, Hwang DH. The phosphatidylinositol 3-kinase/Akt pathway negatively regulates Nod2-mediated NF-kappaB pathway. Biochem Pharmacol 2008; 75: 1515-1525.
37. Schwabe RF, Brenner DA. Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes. Am J Physiol Gastrointest Liver Physiol 2002; 283: G204-G211.
38. Gordon MD, Dionne MS, Schneider DS, Nusse R. WntD is a feedback inhibitor of Dorsal/ NF-kappaB in Drosophila development and immunity. Nature 2005; 437: 746-749.
39. Hansson A, Marin YE, Suh J, Rabson AB, Chen S, Huberman E et al. Enhancement of TPA-induced growth inhibition and apoptosis in myeloid leukemia cells by BAY 11-7082, an NF-kappaB inhibitor. Int J Oncol 2005; 27: 941-948.
40. Juliana C, Fernandes-Alnemri T, Wu J, Datta P, Solorzano L, Yu JW et al. Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome. J Biol Chem 2010; 285: 9792-9802.
41. Garcia MG, Alaniz L, Lopes EC, Blanco G, Hajos SE, Alvarez E. Inhibition of NF-kappaB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines. Leuk Res 2005; 29: 1425-1434.
42. Hwang I, Choi YS, Jeon MY, Jeong S. NF-kappaB p65 represses beta-catenin-activated transcription of cyclin D1. Biochem Biophys Res Commun 2010; 403: 79-84.
43. Solanas G, Porta-de-la-Riva M, Agusti C, Casagolda D, Sanchez-Aguilera F, Larriba MJ et al. E-cadherin controls beta-catenin and NF-kappaB transcriptional activity in mesenchymal gene expression. J Cell Sci 2008; 121: 2224-2234.
44. Saegusa M, Hashimura M, Kuwata T, Hamano M, Okayasu I. Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells. J Pathol 2007; 213: 35-45.